These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

120 related articles for article (PubMed ID: 24556851)

  • 21. Pharmacoepidemiology and the Australian regional prevalence of multiple sclerosis.
    Hollingworth S; Walker K; Page A; Eadie M
    Mult Scler; 2013 Nov; 19(13):1712-6. PubMed ID: 23530000
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Increasing prevalence and incidence of multiple sclerosis in northern Japan.
    Houzen H; Niino M; Hata D; Nakano F; Kikuchi S; Fukazawa T; Sasaki H
    Mult Scler; 2008 Aug; 14(7):887-92. PubMed ID: 18573833
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hospital admissions associated with gout and their comorbidities in New Zealand and England 1999-2009.
    Robinson PC; Merriman TR; Herbison P; Highton J
    Rheumatology (Oxford); 2013 Jan; 52(1):118-26. PubMed ID: 22989425
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Prevalence of multiple sclerosis in Isfahan, Iran.
    Etemadifar M; Janghorbani M; Shaygannejad V; Ashtari F
    Neuroepidemiology; 2006; 27(1):39-44. PubMed ID: 16804333
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The prevalence of multiple sclerosis in the Middle East.
    Al-Hashel J; Besterman AD; Wolfson C
    Neuroepidemiology; 2008; 31(2):129-37. PubMed ID: 18716409
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Prevalence of multiple sclerosis in Colombia].
    Sánchez JL; Aguirre C; Arcos-Burgos OM; Jiménez I; Jiménez M; León F; Pareja J; Pradilla G; Uribe B; Uribe CS; Villa A; Volcy M; Palacio LG
    Rev Neurol; 2000 Dec 16-31; 31(12):1101-3. PubMed ID: 11205538
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of ethnicity on the characteristics of multiple sclerosis: a local population study between Persians and Arabs.
    Sharafaddinzadeh N; Moghtaderi A; Majdinasab N; Dahmardeh M; Kashipazha D; Shalbafan B
    Clin Neurol Neurosurg; 2013 Aug; 115(8):1271-5. PubMed ID: 23273383
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epidemiology of multiple sclerosis in Iran: a systematic review.
    Etemadifar M; Sajjadi S; Nasr Z; Firoozeei TS; Abtahi SH; Akbari M; Fereidan-Esfahani M
    Eur Neurol; 2013; 70(5-6):356-63. PubMed ID: 24192707
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Multiple sclerosis in southern Europe: Monreale City, Italy. A twenty-year follow-up incidence and prevalence study.
    Ragonese P; Salemi G; D'Amelio M; Gammino M; Aridon P; Savettieri G
    Neuroepidemiology; 2004; 23(6):306-9. PubMed ID: 15297798
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Method for identifying eligible individuals for a prevalence survey in the absence of a disease register or population register.
    Richardson AK; Clarke G; Sabel CE; Pearson JF; Mason DF; Taylor BV
    Intern Med J; 2012 Nov; 42(11):1207-12. PubMed ID: 22373014
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Multiple sclerosis in Australia and New Zealand: are the determinants genetic or environmental?
    Miller DH; Hammond SR; McLeod JG; Purdie G; Skegg DC
    J Neurol Neurosurg Psychiatry; 1990 Oct; 53(10):903-5. PubMed ID: 2266373
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Region with persistent high frequency of multiple sclerosis in Croatia and Slovenia.
    Peterlin B; Ristić S; Sepcić J; Vracko BK; Rako A; Lovrecić L; Brajenović-Milić B; Rudez J; Materljan E; Kapović M
    J Neurol Sci; 2006 Sep; 247(2):169-72. PubMed ID: 16806273
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study.
    Maghzi AH; Ghazavi H; Ahsan M; Etemadifar M; Mousavi S; Khorvash F; Minagar A
    Mult Scler; 2010 Mar; 16(3):359-61. PubMed ID: 20086021
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Sharp increase in the incidence and prevalence of multiple sclerosis in Isfahan, Iran.
    Etemadifar M; Maghzi AH
    Mult Scler; 2011 Aug; 17(8):1022-7. PubMed ID: 21459809
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Prevalence of multiple sclerosis: door-to-door survey in three rural areas of coastal Black Sea regions of Turkey.
    Börü UT; Taşdemir M; Güler N; Ayık ED; Kumaş A; Yıldırım S; Duman A; Sur H; Kurtzke JF
    Neuroepidemiology; 2011; 37(3-4):231-5. PubMed ID: 22133733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Multiple sclerosis in Iran: a demographic study of 8,000 patients and changes over time.
    Sahraian MA; Khorramnia S; Ebrahim MM; Moinfar Z; Lotfi J; Pakdaman H
    Eur Neurol; 2010; 64(6):331-6. PubMed ID: 21071949
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Possible increasing risk of multiple sclerosis in Catania, Sicily.
    Nicoletti A; Patti F; Lo Fermo S; Sorbello V; Reggio E; Maimone D; Zappia M; Reggio A
    Neurology; 2005 Oct; 65(8):1259-63. PubMed ID: 16247054
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Occurrence of multiple sclerosis in central Finland: a regional and temporal comparison during 30 years.
    Sarasoja T; Wikström J; Paltamaa J; Hakama M; Sumelahti ML
    Acta Neurol Scand; 2004 Nov; 110(5):331-6. PubMed ID: 15476462
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multiple sclerosis in Isfahan, Iran.
    Saadatnia M; Etemadifar M; Maghzi AH
    Int Rev Neurobiol; 2007; 79():357-75. PubMed ID: 17531850
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Prevalence of multiple sclerosis door-to-door survey in Maltepe, Istanbul, Turkey.
    Türk Börü U; Alp R; Sur H; Gül L
    Neuroepidemiology; 2006; 27(1):17-21. PubMed ID: 16770082
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.